$4.90
-0.02-0.42%
At Close: -
$5.10
0.24.08%
After Hours: 8:04 AM EDT
15 minutes delayed
Intensity Therapeutics
INTSNASDAQ
Intensity Therapeutics (NASDAQ:INTS) Stock, Earnings Estimates, EPS, And Revenue
Intensity Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-0.340
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Intensity Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTS | Intensity Therapeutics | -$0.79 | — | — | — | $0.00 | — | — | — | 08/12/2024 | Get Alert |
| INTS | Intensity Therapeutics | -$0.39 | — | -$0.34 | — | — | — | $0.00 | — | 05/09/2024 | Get Alert |
| INTS | Intensity Therapeutics | — | -$0.18 | -$0.12 | 33.33% | — | — | $0.00 | — | 03/14/2024 | Get Alert |
| INTS | Intensity Therapeutics | -$0.52 | -$0.09 | -$0.17 | -88.89% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| INTS | Intensity Therapeutics | — | -$0.40 | -$0.79 | -97.50% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
Intensity Therapeutics (INTS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-03-14 | $-0.12 | $-0.18 | 33.3 % |
| Sep 2023 | 2023-11-13 | $-0.17 | $-0.09 | -88.9 % |
| Jun 2023 | 2023-08-14 | $-0.79 | $-0.40 | -97.5 % |
Intensity Therapeutics (INTS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Intensity Therapeutics (NASDAQ:INTS) reporting earnings?
Intensity Therapeutics (INTS) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Intensity Therapeutics (NASDAQ:INTS)?
The Actual EPS was $-0.34, which missed the estimate of $0.00.
What were Intensity Therapeutics’s (NASDAQ:INTS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.